Table III.
Ordered logistic analysis of the first therapeutic-target-achieving time.
| 95% CI for OR | |||||
|---|---|---|---|---|---|
| Indicator | OR | Wald's χ2 | P-value | Lower bound | Upper bound |
| Initial dosage (mg) | |||||
| 1 (2.5) | 4.516 | 7.547 | 0.007 | 3.511 | 5.521 |
| 2 (3) | 2.217 | 5.840 | 0.022 | 1.327 | 3.107 |
| 3 (5) | 1 | ||||
| BMI | |||||
| 0 (18.5–23.9) | 0.122 | 9.724 | 0.003 | 0.030 | 0.493 |
| 1 (24–26.9) | 0.208 | 5.100 | 0.024 | 0.053 | 0.813 |
| 2 (27–29.9) | 2.081 | 1.221 | 0.269 | 0.567 | 7.652 |
| 3 (>30) | 1 | ||||
| Liver function | |||||
| 0 (abnormal) | 0.011 | 7.699 | 0.006 | 0.002 | 0.068 |
| 1 (normal) | 1 | ||||
| Heart failure | |||||
| 0 (yes) | 0.025 | 8.740 | 0.002 | 0.003 | 0.190 |
| 1 (no) | 1 | ||||
| Blood circulation-activating TCM | |||||
| 0 (not used) | 1.863 | 3.583 | 0.058 | 0.978 | 3.547 |
| 1 (used) | 1 | ||||
| Cephalosporin | |||||
| 0 (not used) | 1.818 | 3.660 | 0.056 | 0.985 | 3.353 |
| 1 (used) | 1 | ||||
| Levofloxacin | |||||
| 0 (not used) | 1.375 | 10.451 | 0.001 | 1.565 | 9.994 |
| 1 (used) | 1 | ||||
Among groups, P<0.05 was considered significant. Ordered logistic analysis was used for statistics. OR, odds ratio; CI, confidence interval; BMI, body mass index.